跳至主要内容
临床试验/NCT03192670
NCT03192670Unknown不适用

A Study of Low-level Light Therapy Using Photo-activated Modulation Ameliorates Cognitive Deficits by Enhancing Cerebral Blow Flow

Yong-il Shin, MD2 个研究点 分布在 1 个国家目标入组 168 人开始时间: 2017年6月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
168
试验地点
2
主要终点
Neuropsychological Behavioral Assessment 1

研究概览

简要总结

The primary objective of this study is to confirm and compare the effect of methods of Low-level light therapy (LED-T) in the mild cognitive impairment.

详细描述

Total 168 patients were recruited and randomized to receive either real or sham-LED-T. Real experimental groups were divided into three groups; CA group, VA group, CA+VA dual group. Each group received LED-T (30 min) once a day for 30 days. Each groups LED-T positioned at following locations;

  • CA group on the superior border of the thyroid cartilage, and anterior to the sternocleidomastoid muscle based on Korea traditional therapy called Inyoung(ST9)
  • VA group on the upper abdomen, spinous process of the 2nd cervical vertebra upper margin based on Korea traditional therapy called CunChu
  • CA+VA dual group on the CA position (ST9), and VA position (BL10) The patients were initially evaluated at baseline, immediately, 4wks after intervention.

Study type : Interventional Study Phase : Not provided Study Design : Allocation : Randomized Intervention Model : Parallel Assignment Masking : Single Blind (Investigator) Primary Purpose : Treatment, intervention Condition : Mild cognitive impairment, Health subjects

Intervention :

  • Low-level light therapy device (Peak wavelength:610nm, Power intensity: 1.7mW/cm2, Energy density: 2.0J/cm2, Skin-adhesive light-emitting probes: spot size, 1cm diameter),
  • Parameters : Neuroimaging assessement: fMRI, SPECT, Neuropsychological behavioral assessment: SNSB; Seoul Neuropsychological screening battery, K-MoCA, Corsi-block test, K-MBI, K-ADL, GDS, EQ-5D, Neurophysiological assessment: MEP, Motor evoked potential, Gene test(BNDF, ApoE)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
55 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects ages older than 55 years old
  • Subjects who has K-MoCA assessment score less than 23
  • Subjects who understand the purpose of the study and acquired the consent of the subjects or caregiver

排除标准

  • Subjects who have K-MMSE less than 19
  • Subjects who have pre-existing and present-existing neurological diseases as CNS lesion
  • Subjects who have psychiatric disease such as depression, schizophrenia, bipolar disease, or dementia
  • Subjects who is estimated as not appropriate for the study by the investigators

结局指标

主要结局

Neuropsychological Behavioral Assessment 1

时间窗: Baseline, Change from Baseline SNSB at immediately after intervention , Change from Baseline SNSB at 4 weeks after intervention

SNSB

次要结局

  • Neuropsychological Behavioral Assessment 3(Baseline, Change from Baseline K-MoCA at immediately after intervention , Change from Baseline K-MoCA at 4 weeks after intervention)
  • Depression assessment(Baseline, Change from Baseline GDS-SF at immediately after intervention , Change from Baseline GDS-SF at 4 weeks after intervention)
  • Neuroimaging Assessment 1(Baseline, Change from Baseline fMRI at immediately after intervention , Change from Baseline fMRI at 4 weeks after intervention)
  • ADL assessment 2(Baseline, Change from Baseline K-ADL at immediately after intervention , Change from Baseline K-ADL at 4 weeks after intervention)
  • Neuropsychological Behavioral Assessment 2(Baseline, Change from Baseline Corsi-block test at immediately after intervention , Change from Baseline Corsi-block test at 4 weeks after intervention)
  • Neuroimaging Assessment 2(Baseline, Change from Baseline SPECT at immediately after intervention , Change from Baseline SPECT at 4 weeks after intervention)
  • ADL assessment 1(Baseline, Change from Baseline K-MBI at immediately after intervention , Change from Baseline K-MBI at 4 weeks after intervention)
  • Quality of Life assessment(Baseline, Change from Baseline EQ-5D at immediately after intervention , Change from Baseline EQ-5D at 4 weeks after intervention)
  • Gene test 1(Baseline, Change from Baseline BNDF at immediately after intervention , Change from Baseline BNDF at 4 weeks after intervention)
  • Gene test 2(Baseline, Change from Baseline ApoE at immediately after intervention , Change from Baseline ApoE at 4 weeks after intervention)

研究者

发起方
Yong-il Shin, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yong-il Shin, MD

Professor

Pusan National University

研究点 (2)

Loading locations...

相似试验